<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01621945</url>
  </required_header>
  <id_info>
    <org_study_id>2011/198/HP</org_study_id>
    <nct_id>NCT01621945</nct_id>
  </id_info>
  <brief_title>Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 in Patients Having to be Vaccinated MenBVac® (Extension EFFIVAC)</brief_title>
  <acronym>Exten Effivac</acronym>
  <official_title>Phase 3, Vaccinal Activity Assessment of MenBVac Against Neisseria Meningitidis B:14,P1.7,16 Strain in Child</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Direction Générale de la Santé, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut Pasteur</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of the study is to estimate the proportion of children, born between the
      06/04/2004 and the 17/004/2008, living around Neufchatel en Bray, vaccinated by MenBVac, with
      a serum bactericidal activity against B:14,P1-7,16 clone related to a protection (&gt;= 4),
      before the fourth dose of MenBvac and after: 6 weeks and one year after the fourth dose.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Vaccine Immunity</measure>
    <time_frame>after the fourth dose of MenbVac</time_frame>
    <description>Assessment of vaccine Immunity with measure of percentage of children who have hSBA title &gt;= 4 six weeks after the fourth dose of vaccine</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">120</enrollment>
  <condition>Neisseria Meningitidis</condition>
  <arm_group>
    <arm_group_label>Bras A</arm_group_label>
    <description>children, born between the 06/04/2004 and the 17/04/2008, living around Neufchatel en Bray, before the fourth dose of MenBVac</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>MenBvac</intervention_name>
    <description>Blood test</description>
    <arm_group_label>Bras A</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children aged 4 to 8 years old and living in neufchatel en bray area
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children born between 06/04/2004 and 17/04/2008, living in Neufchatel en Bray,and
             Having participated to the first study,

          -  children who Have to be Vaccinated MenBVac® for the four times,

          -  parental authority(ies)assent.

        Exclusion Criteria:

          -  no parental authority(ies)assent,

          -  no blood sample,

          -  impossibility of fourth vaccination,

          -  children yet vaccinated or non eligible for vaccination.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>8 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Maison Du Département</name>
      <address>
        <city>Neufchâtel En Bray</city>
        <zip>76270</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2012</study_first_submitted>
  <study_first_submitted_qc>June 15, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 18, 2012</study_first_posted>
  <last_update_submitted>September 5, 2014</last_update_submitted>
  <last_update_submitted_qc>September 5, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 8, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neisseria meningitidis B:14, P1-7, 16</keyword>
  <keyword>Serum bactericidal activity</keyword>
  <keyword>OMV vaccine</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

